financetom
Business
financetom
/
Business
/
Science Applications International, ServiceNow Collaborate on Government Risk Reduction Platform
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Science Applications International, ServiceNow Collaborate on Government Risk Reduction Platform
Jul 7, 2025 7:51 AM

10:15 AM EDT, 07/07/2025 (MT Newswires) -- Science Applications International ( SAIC ) said Monday it is collaborating with ServiceNow ( NOW ) to launch a new government risk reduction platform to enhance IT mission resilience across US armed forces, intelligence and civilian agencies.

The new offering integrates the ServiceNow AI platform into SAIC's mission labs, enabling agencies to shift from reactive risk responses to autonomous resilience, the company said.

SAIC said the partnership will allow government clients to rapidly develop, test and deploy secure, outcome-based IT services.

Financial terms of the deal weren't disclosed.

Price: 118.71, Change: +0.13, Percent Change: +0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Aptevo Therapeutics Shares Friday?
What's Going On With Aptevo Therapeutics Shares Friday?
Nov 29, 2024
Aptevo Therapeutics, Inc. ( APVO ) stock is trading lower Friday after the company announced a 1-for-37 reverse stock split. The Details: The goal of the reverse stock split is to regain compliance with minimum bid price requirement of $1.00 per share required to maintain continued listing on the Nasdaq. Shares will begin trading on a split-adjusted basis on December 4 at...
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Nov 29, 2024
12:15 PM EST, 11/29/2024 (MT Newswires) -- Applied Therapeutics' ( APLT ) lead drug candidate, govorestat, likely faces significant uncertainty in potentially treating galactosemia after the US Food and Drug Administration rejected the biopharmaceutical company's drug application, RBC Capital Markets said Friday. Late Wednesday, the clinical-stage company said the FDA is unable to approve govorestat's new drug application for the...
Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds
Market Chatter: Grifols in Talks With Banks to Extend Credit Facility, Refinance Bonds
Nov 29, 2024
12:17 PM EST, 11/29/2024 (MT Newswires) -- Grifols ( GRFS ) is in discussions with banks to extend a $1 billion revolving credit facility and refinance 370 million euros ($390.3 million) in bonds due 2025, Bloomberg News reported Thursday, citing an interview with Chief Executive Officer Nacho Abia. Several banks have already confirmed interest in refinancing, even expanding the facility,...
EU regulators scrap merger power aimed at killer acquisitions after court veto
EU regulators scrap merger power aimed at killer acquisitions after court veto
Nov 29, 2024
BRUSSELS (Reuters) - EU antitrust regulators on Friday ditched a merger tool aimed at killer acquisitions two months after Europe's top court vetoed this expanded merger power which had been widely criticised by companies as regulatory over-reach. The Luxembourg-based Court of Justice in September sided with Illumina ( ILMN ) in its fight against the European Commission's decision to wield...
Copyright 2023-2026 - www.financetom.com All Rights Reserved